Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies

Rodney Varner , CEO of Genprex, Inc. today commended The U.S. Food and Drug Administration’s (FDA) initiative that aims to expedite the development of gene therapies for patients with rare diseases.